Cargando…
The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer
WNT signaling plays a key role in the self-renewal of tumor initiation cells (TICs). In this study, we used pyrvinium pamoate (PP), an FDA-approved antihelmintic drug that inhibits WNT signaling, to test whether pharmacologic inhibition of WNT signaling can specifically target TICs of aggressive bre...
Autores principales: | Xu, Wei, Lacerda, Lara, Debeb, Bisrat G., Atkinson, Rachel L., Solley, Travis N., Li, Li, Orton, Darren, McMurray, John S., Hang, Brian I., Lee, Ethan, Klopp, Ann H., Ueno, Naoto T., Reuben, James M., Krishnamurthy, Savitri, Woodward, Wendy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754994/ https://www.ncbi.nlm.nih.gov/pubmed/24013655 http://dx.doi.org/10.1371/journal.pone.0071508 |
Ejemplares similares
-
Pyrvinium Pamoate and Structural Analogs Are Early Macrofilaricide Leads
por: Gunderson, Emma L., et al.
Publicado: (2022) -
Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model
por: Lacerda, Lara, et al.
Publicado: (2015) -
Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug
por: Schultz, Christopher W., et al.
Publicado: (2022) -
Pyrvinium pamoate can overcome artemisinin’s resistance in anaplastic thyroid cancer
por: Li, Yitian
Publicado: (2021) -
Synergistic Effect of Pyrvinium Pamoate and Azoles Against Aspergillus fumigatus in vitro and in vivo
por: Sun, Yi, et al.
Publicado: (2020)